Portage Biotech company info

What does Portage Biotech do?
Portage Biotech (NASDAQ:PRTG) is a biotechnology firm focused on the development of innovative therapies in the fields of immuno-oncology and cancer treatment. The company works on advancing its pipeline of products through strategic collaborations, leveraging cutting-edge science to address unmet medical needs. Portage Biotech's projects span various stages of development, aiming to bring novel treatments from the laboratory to the clinic. The primary objective of Portage is to improve patient outcomes by harnessing the body's immune response to fight cancer, demonstrating its commitment to transforming the landscape of cancer therapy.
Portage Biotech company media
Company Snapshot

Is Portage Biotech a public or private company?


How many people does Portage Biotech employ?


What sector is Portage Biotech in?

pie chart
Health Care

Where is the head office for Portage Biotech?

location pin
Head Office
Westport, United States

What year was Portage Biotech founded?

founded flag
Year Founded
What does Portage Biotech specialise in?
/Biopharmaceutical Development /Drug Discovery /Oncology Therapies /Cosmetic Treatments /Immunotherapy Products /Project Investments

What are the products and/or services of Portage Biotech?

Overview of Portage Biotech offerings
INT230-6, a novel formulation for direct tumor injection aimed at maximizing drug distribution within tumors.
PORT-2, utilizing a thio-bridge technology to generate antibody-drug conjugates for cancer therapy.
PORT-3, a nanolipogel platform for dual delivery of immune-modulating agents, enhancing anti-tumor efficacy.
PORT-4, leveraging AI to identify and develop novel immuno-oncology targets.
Biohaven Ltd., partnership focusing on the development and commercialization of late-stage assets in immunology and oncology.

Who is in the executive team of Portage Biotech?

Portage Biotech leadership team
  • Dr. Ian B. Walters M.B.A., M.D.
    Dr. Ian B. Walters M.B.A., M.D.
    CEO & Chairman of Board
  • Mr. Allan J. Lee Shaw CPA
    Mr. Allan J. Lee Shaw CPA
    Chief Financial Officer
  • Dr. Robert A. Kramer Ph.D.
    Dr. Robert A. Kramer Ph.D.
    Chief Scientific Officer
  • Mr. Brian  Wiley
    Mr. Brian Wiley
    Chief Business Officer
  • Mr. Justin  Fairchild
    Mr. Justin Fairchild
    Vice President of Development
  • Mr. Joseph  Ciavarella
    Mr. Joseph Ciavarella
    Chief Accounting Officer